This is the case with ovarian cancer tumor-initiating cells, intrinsically marked by decreased expression of ferroportin (FPN), an iron efflux pump, and increased expression of transferrin receptor (TfR1), an iron importer. The gene discussed is SLC40A1; the disease is ovarian carcinoma.